EVIDENCE 360: The Intersection of RWE, Pricing, and Reimbursement in Pharma
The landscape of Real-World Evidence (RWE) is evolving rapidly, shaping the future of healthcare decision-making, market access, and pricing strategies. If you are involved in the pharmaceutical, biotech, academic, or regulatory sectors, the Real-World Evidence Summit in Germany, also known as RWE E